Works matching IS 14741776 AND DT 2012 AND VI 11 AND IP 9

Results: 25

Mark McClellan. Interview by Asher Mullard.

Published in:

2012

By:

McClellan M

Publication type:

Journal Article

Amyloid diseases: Targeting filamin A reduces Alzheimer's signalling.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 674, doi. 10.1038/nrd3832

By:

Harrison, Charlotte

Publication type:

Article

Leptin revisited: its mechanism of action and potential for treating diabetes.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 692, doi. 10.1038/nrd3757

By:

Coppari, Roberto;
Bjørbæk, Christian

Publication type:

Article

Mark McClellan.

Published in:: 2012
Publication type:: Interview

Cancer: Passenger deletions create cancer-specific Achilles heel.

Published in:

2012

By:

Flemming, Alexandra

Publication type:

journal article

Structure-based drug design: Opening the door to an epigenetic target.

Published in:

2012

By:

Harrison, Charlotte

Publication type:

journal article

Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 675, doi. 10.1038/nrd3739

By:

Dietrich, Marcelo O.;
Horvath, Tamas L.

Publication type:

Article

Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity'?

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 730, doi. 10.1038/nrd3503-c1

By:

Lentini, Giovanni

Publication type:

Article

Europe sets out to reform its clinical trial rules.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 660, doi. 10.1038/nrd3843

By:

Cressey, Daniel

Publication type:

Article

Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 730, doi. 10.1038/nrd3503-c2

By:

Orchard, Sandra;
Al-Lazikani, Bissan;
Bryant, Steve;
Clark, Dominic;
Calder, Elizabeth;
Dix, Ian;
Engkvist, Ola;
Forster, Mark;
Gaulton, Anna;
Gilson, Michael;
Glen, Robert;
Grigorov, Martin;
Hammond-Kosack, Kim;
Harland, Lee;
Hopkins, Andrew;
Larminie, Christopher;
Lynch, Nick;
Mann, Romeena K.;
Murray-Rust, Peter;
Piparo, Elena Lo

Publication type:

Article

Autophagy modulation as a potential therapeutic target for diverse diseases.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 709, doi. 10.1038/nrd3802

By:

Rubinsztein, David C.;
Codogno, Patrice;
Levine, Beth

Publication type:

Article

Regulatory watch: Pioneering gene therapy on brink of approval.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 664, doi. 10.1038/nrd3835

By:

Flemming, Alexandra

Publication type:

Article

HIV: Waking up latent HIV.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 674, doi. 10.1038/nrd3833

By:

Harrison, Charlotte

Publication type:

Article

Down's syndrome and Alzheimer's disease: towards secondary prevention.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 655, doi. 10.1038/nrd3822

By:

Ness, Seth;
Rafii, Michael;
Aisen, Paul;
Krams, Michael;
Silverman, Wayne;
Manji, Husseini

Publication type:

Article

PDUFA V goes back to basics.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 730, doi. 10.1038/nrd3824

By:

Mullard, Asher

Publication type:

Article

News in brief.

Published in:: Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 663, doi. 10.1038/nrd3840
Publication type:: Article

Anticancer drugs: Reactivating p53 tumour suppressor function.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 674, doi. 10.1038/nrd3834

By:

Harrison, Charlotte

Publication type:

Article

Ischaemic disorders: Nanotherapeutic delivers clot-busting drug.

Published in:

2012

By:

Crunkhorn, Sarah

Publication type:

journal article

In this issue.

Published in:: Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 653, doi. 10.1038/nrd3839
Publication type:: Article

Patent watch.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 666, doi. 10.1038/nrd3841

By:

Harrison, Charlotte

Publication type:

Article

Antisense therapeutics: Nuclear RNA more susceptible to knockdown.

Published in:

2012

By:

Tse, Man Tsuey

Publication type:

journal article

Vaccination: Oral vaccine induces genitorectal immunity.

Published in:

2012

By:

Hutchinson, Ezzie

Publication type:

journal article

Sting of Alzheimer's failures offset by upcoming prevention trials.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 657, doi. 10.1038/nrd3842

By:

Mullard, Asher

Publication type:

Article

The pharmaceutical market for obesity therapies.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 669, doi. 10.1038/nrd3830

By:

Wong, Donny;
Sullivan, Kate;
Heap, Gideon

Publication type:

Article

Trial watch: HIV integrase inhibitor-based regimen beats market leader.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 664, doi. 10.1038/nrd3836

By:

Crunkhorn, Sarah

Publication type:

Article